Study guide

9.3 Medication Delivery Devices, Home Infusion & Patient Education

BCSCP Board Certified Sterile Compounding Pharmacist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, USP Standards & CSP Categories

1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions

2 Chapter 2: Facilities, Engineering Controls & Cleaning

2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

3 Chapter 3: Environmental Monitoring & Facility Certification

3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols

4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique

4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

5 Chapter 5: Beyond-Use Dating, Storage & Container Rules

5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules

6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding

6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)

7 Chapter 7: Materials, Equipment & Compounding Workflow

7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs

8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility

8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics

9 Chapter 9: Therapeutics, Administration & Patient Monitoring

9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations

10 Chapter 10: Quality Management, Records & Personnel Competency

10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence

11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain

11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA

12 Chapter 12: Safety Management, Investigations, Recalls & Waste

12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management

9.3 Medication Delivery Devices, Home Infusion & Patient Education

Key Takeaways Explain This Topic AI

Smart infusion pumps with dose error reduction software check programmed doses against a drug library. A hard limit cannot be overridden, while a soft limit can be overridden after confirmation.

Elastomeric pump flow depends on temperature, fill volume and solution viscosity. A warmer reservoir or a less viscous diluent speeds the infusion, so compounding must match the manufacturer's specified fill volume and diluent.

Implanted intrathecal pumps are refilled with preservative-free CSPs at exact concentrations; refill errors such as pocket fills or wrong concentrations can be fatal, so concentrations and volumes are independently verified.

Home infusion needs BUDs long enough for the delivery schedule (often Category 2 or 3 CSPs, or 503B products), validated shipping, and clear home storage instructions.

Patient education uses teach-back and covers storage, hand hygiene and scrub-the-hub technique, pump operation and alarms, warning signs of infection, occlusion or extravasation, disposal of sharps and HD waste, and who to call.

Last updated: September 2026

9.3 Medication Delivery Devices, Home Infusion & Patient Education

The BCSCP outline pairs compounding with administration (task 2A3): routes, delivery devices, home infusion and patient education. The device often decides the concentration, the volume, the container and the BUD, so the compounding pharmacist has to understand how each device works.

Infusion devices and what they require from the CSP

Device Key features Compounding implications

Large-volume smart pump Drug library with dose error reduction software (DERS); hard and soft limits Use standardized concentrations that match the library entries

Syringe pump Precise low flow rates; startup delay with small syringes Syringe size and brand must match the pump; neonatal concentrations standardized

PCA pump Patient-activated boluses with lockout Standard opioid concentrations; tamper-resistant cassettes; high-alert double checks

Ambulatory electronic pump (e.g., cassette pumps) Programmable continuous or intermittent home infusion Cassette volume, concentration and BUD must cover the interval between deliveries

Elastomeric pump Nonelectronic balloon reservoir; fixed flow restrictor Fill to the specified volume with the specified diluent; flow varies with temperature and viscosity

Implanted intrathecal pump Programmable reservoir refilled through the skin Preservative-free CSP at the exact concentration; volume and concentration verified independently

  • Gravity infusion Rate set by roller clamp and drop counting Simple, but inaccurate for high-alert drugs
  • Smart pumps and DERS

A hard limit blocks programming beyond a set dose or rate and cannot be overridden. A soft limit warns and requires confirmation. Drug library entries only work if the compounded concentration matches the library exactly. A nonstandard concentration forces a "basic infusion" with no safety net. Pump interoperability with the electronic health record, where the order auto-programs the pump, reduces keying errors.

Elastomeric pumps

Their stated flow rate assumes a particular temperature , fill volume and diluent , usually 0.9% sodium chloride or dextrose 5%. A reservoir worn close to the body runs faster than one at room temperature. A more viscous solution runs slower , and underfilling or overfilling changes the rate. Compound exactly to the manufacturer's volume and diluent, and teach patients where to wear the device.

Implanted intrathecal pumps

These pumps deliver drugs such as morphine, baclofen and ziconotide straight into the cerebrospinal fluid. Only preservative-free CSPs are used, and endotoxin limits are strict ( K = 0.2 EU/kg K = 0.2\,\text{EU/kg} K = 0.2 EU/kg ). Refill errors are deadly. A pocket fill means drug injected into the tissue pocket instead of the reservoir. Other errors are a wrong concentration or programming that does not match the concentration in the reservoir. Label the concentration clearly, verify it independently, and make sure the programmer's settings match the CSP.

Delivery details that change the dose

Residual tubing volume: An IV piggyback run through a secondary set can leave several milliliters in the tubing. If that line is not flushed, part of the dose is never given, which matters most for small-volume antibiotics and chemotherapy.

Overfill: Commercial bags contain overfill, which changes the true concentration of an admixture. Standardized recipes should account for it when concentration matters.

In-line filters and sets: Some drugs need specific filters (0.2 µm for many; 1.2 µm for lipid-containing PN) or PVC-free, light-protected sets (see 8.2).

Route-specific connectors: Use NRFit for neuraxial devices and ENFit for enteral ones (see 7.2).

Home infusion

Home infusion moves sterile therapy (antibiotics, PN, inotropes, chemotherapy, biologics) into the patient's home. It adds several demands:

Patient selection: A safe home environment, a willing and capable patient or caregiver, reliable vascular access, and a way to reach help 24 hours a day.

Dating for the delivery schedule: Weekly deliveries need BUDs of 7 days or more. That often means Category 2 CSPs with sterility testing, Category 3 CSPs, or outsourced 503B products with expiration dates, in each case supported by stability data.

Shipping and storage: Validated coolers and temperature indicators for transport (see 7.6), and a clear place for refrigerated storage at home, away from food.

Coordination: Home health nursing, the prescriber, the laboratory for monitoring, and the supplier of pumps and supplies (see 9.7).

Patient and caregiver education

Use teach-back : have the learner explain or demonstrate each step, rather than just asking, "Do you understand?" Core content:

Storage and preparation: refrigeration, bringing the CSP to room temperature, checking the label and BUD, and inspecting for particles, cloudiness or leaks

Aseptic handling: hand hygiene, clean work surface, scrub the hub with alcohol and friction, never touch connectors

Pump operation: starting and stopping, common alarms (occlusion, air in line, low battery) and what to do

Line care: flushing (saline-administration-saline sequences, with heparin only if prescribed), dressing protection

Warning signs: fever or chills (possible bloodstream infection), redness, pain or swelling at the site (phlebitis or extravasation), line occlusion, and allergic reactions

  • Disposal: sharps containers, and for hazardous drugs, gloves and the disposal method provided
  • Who to call , around the clock

Education and each teach-back are documented, and understanding is rechecked at follow-up visits.